Jonathan Sheena, a director at $NTRA, sold 181 shares of the company on 03-17-2025 for an estimated $26,431. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their shares of this class of stock. Following this trade, they now own 261,019 shares of this class of $NTRA stock.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 200 times in the past 6 months. Of those trades, 0 have been purchases and 200 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 20 sales selling 221,130 shares for an estimated $35,729,673.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 21 sales selling 195,323 shares for an estimated $29,807,236.
- ROELOF BOTHA has made 0 purchases and 5 sales selling 87,473 shares for an estimated $14,793,563.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 24 sales selling 85,958 shares for an estimated $14,425,269.
- JONATHAN SHEENA has made 0 purchases and 69 sales selling 72,869 shares for an estimated $11,080,577.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 19 sales selling 47,752 shares for an estimated $7,668,048.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 11 sales selling 35,836 shares for an estimated $5,877,047.
- ROY D. BAYNES has made 0 purchases and 6 sales selling 37,230 shares for an estimated $5,439,564.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 13 sales selling 28,855 shares for an estimated $4,686,103.
- GAIL BOXER MARCUS has made 0 purchases and 11 sales selling 15,894 shares for an estimated $2,490,375.
- ROWAN E CHAPMAN sold 1,767 shares for an estimated $300,808
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 294 institutional investors add shares of $NTRA stock to their portfolio, and 277 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,871,862 shares (+134.9%) to their portfolio in Q4 2024, for an estimated $612,915,754
- JPMORGAN CHASE & CO added 2,069,396 shares (+44.7%) to their portfolio in Q4 2024, for an estimated $327,585,386
- MILLENNIUM MANAGEMENT LLC removed 1,021,889 shares (-72.0%) from their portfolio in Q4 2024, for an estimated $161,765,028
- FRED ALGER MANAGEMENT, LLC removed 994,184 shares (-24.8%) from their portfolio in Q4 2024, for an estimated $157,379,327
- BLACKROCK, INC. added 947,457 shares (+11.5%) to their portfolio in Q4 2024, for an estimated $149,982,443
- ALLIANCEBERNSTEIN L.P. removed 893,203 shares (-53.8%) from their portfolio in Q4 2024, for an estimated $141,394,034
- GOLDMAN SACHS GROUP INC added 887,710 shares (+110.0%) to their portfolio in Q4 2024, for an estimated $140,524,493
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTRA Congressional Stock Trading
Members of Congress have traded $NTRA stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 11/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 03/04/2025
- Bernstein issued a "Outperform" rating on 01/10/2025
- Cowen & Co. issued a "Buy" rating on 11/13/2024
- Jefferies issued a "Buy" rating on 11/13/2024
- Canaccord Genuity issued a "Buy" rating on 10/29/2024
- UBS issued a "Buy" rating on 10/16/2024
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 3 analysts offer price targets for $NTRA in the last 6 months, with a median target of $160.0.
Here are some recent targets:
- Tycho Peterson from Jefferies set a target price of $182.0 on 11/13/2024
- Catherine Ramsey Schulte from Robert W. Baird set a target price of $160.0 on 11/13/2024
- Kyle Mikson from Canaccord Genuity set a target price of $150.0 on 10/29/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
